BackAesther Healthcare Acquisition Overview

Aesther Healthcare Acquisition EBIT

Aesther Healthcare Acquisition's EBIT is $-2.5M, above the sector sector average of $-63M.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

$0.00

As of Mar 31, 2025

Annual EBIT (TTM)

-$2.54M
51.8% YoY

Trailing 12 months ending Mar 31, 2025

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Aesther Healthcare Acquisition (AEHA) FAQ

The latest EBIT for AEHA is $-2.5M as of March 2025. That compares with $-5.3M in the prior-year period — up 51.8% year over year. That is above the sector sector average of $-63M. Investors often review this figure alongside Aesther Healthcare Acquisition's historical trend and sector peers before judging valuation or financial health.

Over the past year, AEHA's EBIT moved from $-5.3M to $-2.5M — a 51.8% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Aesther Healthcare Acquisition's operating scale or balance-sheet position.

Against its sector companies, AEHA currently prints $-2.5M for EBIT, while the sector average sits near $-63M. That is roughly 95.9% above the sector mean. Large gaps often invite a closer look at Aesther Healthcare Acquisition's growth, margins, and balance sheet.

A EBIT figure of $-2.5M for AEHA is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $-63M. Explore the charts below for those layers of context.

After noting AEHA's EBIT ($-2.5M), review year-over-year change from $-5.3M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.